Top Funds / PERCEPTIVE ADVISORS LLC


Joseph Edelman

2020Q2 Portfolio

SEC 13F Filing

Position #Shares $Value % # vs. 2020Q1 $ vs. 2020Q1
AMICUS THERAPEUTICS, INC. 25,182,364 $379,750,000 6.15% No Change +$147,065,000
Global Blood Therapeutics, Inc. 5,842,100 $368,811,000 5.98% -223,626 +$58,914,000
Retrophin, Inc. NOTE 2.500% 9/1 45,000,000 $349,979,000 5.67% New +$349,979,000
IOVANCE BIOTHERAPEUTICS, INC. 11,809,494 $324,170,000 5.25% +139,437 -$25,173,000
Mirati Therapeutics, Inc. 2,771,050 $316,371,000 5.13% -548,400 +$61,204,000
NEUROCRINE BIOSCIENCES INC 2,141,410 $261,252,000 4.23% -921,853 -$3,874,000
CYTOKINETICS INC NOTE 4.000%11/1 10,000,000 $238,260,000 3.86% New +$238,260,000
BridgeBio Pharma, Inc. 6,706,268 $218,691,000 3.54% No Change +$24,210,000
Kodiak Sciences Inc. 3,513,572 $190,154,000 3.08% -149,985 +$15,402,000
VBI Vaccines Inc/BC 55,042,465 $170,631,000 2.76% New +$170,631,000
COLLEGIUM PHARMACEUTICAL, INC NOTE 2.625% 2/1 17,500,000 $157,227,000 2.55% New +$157,227,000
Athenex, Inc. 11,532,467 $155,935,000 2.53% No Change +$66,674,000
SpringWorks Therapeutics, Inc. 3,514,358 $147,603,000 2.39% +30,000 +$53,525,000
MyoKardia, Inc. 1,395,017 $134,787,000 2.18% +80,808 +$73,176,000
ZOGENIX, INC. 4,907,139 $132,542,000 2.15% New +$132,542,000
Zymeworks Inc. 3,580,999 $129,166,000 2.09% +20,000 +$3,074,000
NEVRO CORP NOTE 2.750% 4/0 9,000,000 $121,500,000 1.97% New +$121,500,000
NEVRO CORP 899,972 $107,520,000 1.74% -192,096 +$71,000
Quotient Ltd 13,289,054 $98,338,000 1.59% No Change +$45,847,000
MeiraGTx Holdings plc 6,433,277 $80,544,000 1.31% No Change -$5,919,000
Kadmon Holdings, Inc. 15,711,334 $80,442,000 1.30% No Change +$14,612,000
Frequency Therapeutics, Inc. 3,034,296 $70,547,000 1.14% No Change +$16,507,000
ARENA PHARMACEUTICALS INC 1,095,129 $68,938,000 1.12% New +$68,938,000
Allogene Therapeutics, Inc. 1,543,790 $66,105,000 1.07% No Change +$36,094,000
Provention Bio, Inc. 4,525,711 $63,858,000 1.03% +1,514,137 +$36,151,000